Ledger.Open graph →
SEC Form D · filed December 9, 2013

Aprecia Pharmaceuticals Co

Offering
$36.2M
Sold
$14.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANGHORNE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Donald Wetherhold · LOVELAND, OHExecLawrence Glassmann · Cincinnati, OHDirectorPhilip Cater · George Town, Grand Cayman, Cayman IslandsDirectorRobert Williford · CINCINNATI, OHExecDavid Furniss · CINCINNATI, OHExecMichael Rohlfs · WEST CHESTER, OHExecE T. Arington · Mason, OHDirectorArthur R. Rule, Iv · Toronto, Ontario, CanadaDirectorMichael Lipomi · Dallas, TXDirectorShawn Leimbrock · Santa Barbara, CAExecMarti Ogram · Santa Barbara, CAExecMichael Franco · Santa Barbara, CAExecMatthew Ehrlichman · Seattle, WAExecE T. Arington · Mason, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗